InsidersTradesSigma
Track the 康拓医疗 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 康拓医疗 has recorded 9 reports. Market capitalisation: €2.7bn. The latest transaction was reported on 23 April 2026 (Sale). Among the most active insiders: 朱海龙. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
9 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,800 of 29,063 companies
63.1
score / 100
Value45
Quality82
FCF yld2.6%
Earn yld3.8%
EV/EBITDA20.2x
ROE12%
Gross mgn79%
Net mgn28%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 April 2026
Declarations9 total
9 of 9 declarations
Acerca de 康拓医疗
康拓医疗 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en la Bolsa de Shanghái. Se centra en el desarrollo y la comercialización de soluciones médicas innovadoras.